$5.00Average Price Target
The highest estimate is 5.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
This list is based on the watchlists of people on Stock Events who follow IGC. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops treatments for Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63, IGC-M3, and LMP to treat Alzheimer's disease; IGC-1C for the treatment of metabolic disorders and Alzheimer's disease; and IGC-1A to treat metabolic disorders. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.
Show more...
FAQ
What is IGC Pharma stock price today?▼
The current price of IGC is $0.27 USD — it has decreased by -2.32% in the past 24 hours. Watch IGC Pharma stock price performance more closely on the chart.
What is IGC Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange IGC Pharma stocks are traded under the ticker IGC.
Is IGC Pharma stock price growing?▼
IGC stock has risen by +3.84% compared to the previous week, the month change is a -8.27% fall, over the last year IGC Pharma has showed a -5.05% decrease.
What is IGC Pharma market cap?▼
Today IGC Pharma has the market capitalization of 24.62M
When is the next IGC Pharma earnings date?▼
IGC Pharma is going to release the next earnings report on June 15, 2026.
What were IGC Pharma earnings last quarter?▼
IGC earnings for the last quarter are -0.02 USD per share, whereas the estimation was -0.02 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is IGC Pharma revenue for the last year?▼
IGC Pharma revenue for the last year amounts to 2.54M USD.
What is IGC Pharma net income for the last year?▼
IGC net income for the last year is -14.24M USD.
How many employees does IGC Pharma have?▼
As of April 03, 2026, the company has 67 employees.
In which sector is IGC Pharma located?▼
IGC Pharma operates in the Industrials sector.
When did IGC Pharma complete a stock split?▼
The last stock split for IGC Pharma was on April 19, 2013 with a ratio of 1:10.
Where is IGC Pharma headquartered?▼
IGC Pharma is headquartered in Potomac, US.